An enzyme that degrades kynurenine — a chemical by-product of tryptophan — can promote either neuroprotective or neurotoxic effects in the brain, depending on enzyme’s activity level, according to two recent studies. This suggests that this classical biochemical pathway holds clues for treating schizophrenia and neurodegenerative disease alike.

Read this article at Schizophrenia Research Forum.